23ME-01473 — clinical trials using this drug

Public-registry trials using 23ME-01473 that Eichor's radar has found — 1 trial. All data below is from public sources; Eichor is not affiliated with any sponsor.

Trial	Sponsor	Condition	Phase	Sites
Study of 23ME-01473 in Patients With Advanced Solid Malignancies	23andMe, Inc.	Solid Tumor	PHASE1 / PHASE2	3

Registry history

First registered study	March 2024 — NCT06290388 (23andMe, Inc.)
Registered studies matching this name	1 all-time · 0 currently recruiting

Source: ClinicalTrials.gov, the public trial registry.

Free site-risk snapshot for any of these trials

Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Related drugs & trials

Other Solid Tumor drugs

← Eichor home · All tracked trials · Solid Tumor studies · Weekly briefs

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →